Nurse Practitioner, Family · Houston, TX
NPI
1417312539
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
281 services
Medicare patients, 2024
155
Average age 74
Drug cost, 2024
$4.8M
1,109 prescriptions
Company payments, 2025
$3,272
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica K Deinert was code 99213 (office e&m - established), 142 times for 78 patients. In total Jessica K Deinert billed 281 services in 9 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 142 | 78 | $42.09 | $5,977 |
| 99214 Office E&M - Established | Facility | 79 | 62 | $55.88 | $4,414 |
| 99215 Office E&M - Established | Facility | 35 | 32 | $83.80 | $2,933 |
By year: 2022 $19K for 292 services; 2023 $17K for 322 services; 2024 $14K for 281 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jessica K Deinert prescribed most often to Medicare patients was Xtandi (Enzalutamide), with 237 prescriptions and refills. In total Jessica K Deinert wrote 1,109 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xtandi Enzalutamide | 237 | 242 | 43 | $2.8M |
| Abiraterone Acetate Generic | 151 | 151 | 29 | $79K |
| Prednisone Generic | 134 | 172 | 34 | $730 |
| Nubeqa Darolutamide | 74 | 74 | 15 | $990K |
| Tamsulosin Hcl Generic | 45 | 114 | 18 | $882 |
| Orgovyx Relugolix | 41 | 43 | 14 | $109K |
| Bicalutamide Generic | 31 | 67 | Under 11 | $787 |
| Erleada Apalutamide | 28 | 36 | Under 11 | $310K |
| Eliquis Apixaban | 26 | 32 | Under 11 | $15K |
| Amlodipine Besylate Generic | 24 | 60 | Under 11 | $221 |
| Dexamethasone Generic | 22 | 22 | Under 11 | $249 |
| Dutasteride Generic | 20 | 32 | Under 11 | $307 |
| Talzenna Talazoparib Tosylate | 19 | 19 | Under 11 | $265K |
| Lisinopril Generic | 19 | 41 | Under 11 | $110 |
| Gabapentin Generic | 19 | 23 | Under 11 | $243 |
Brand drugs: 452 claims; generic drugs: 657 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica K Deinert $3,272 ($3,272 in general payments such as food, travel and fees) from 8 companies. The largest payer was Janssen Biotech, Inc. with $1,768.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.